About this trial
Age-related decrease in testosterone levels in men is associated with multiple metabolic, functional and psychosocial consequences. Early identification of modifiable factors associated with decreased testosterone levels may contribute to improved prevention of androgen deficiency and related health conditions.
This population-based analytical cross-sectional observational study aims to investigate anthropometric, functional and lifestyle-related factors associated with decreased total testosterone levels in middle-aged men. Approximately 600 men aged 35-59 years residing in the Andijan region of Uzbekistan will be recruited.
Participants will undergo comprehensive assessment including anthropometric measurements, functional performance tests, standardized questionnaires and laboratory determination of serum total testosterone levels. Anthropometric variables will include body mass index, waist circumference, hip circumference, waist-to-hip ratio and waist-to-height ratio. Functional status will be assessed using hand-grip strength, five-times chair-stand test, 4-meter walk test, balance assessment and the six-minute walk test. Lifestyle-related factors including physical activity, sleep quality, dietary habits, smoking, alcohol consumption and psychoemotional status will be evaluated using validated questionnaires.
The study aims to identify determinants of decreased testosterone levels and develop a predictive model for early identification of androgen deficiency in middle-aged men.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Men aged 35-59 years
Permanent residence in the Andijan region of Uzbekistan
Ability to undergo anthropometric measurements and functional performance tests
Ability to complete study questionnaires
Disqualifiers
Previously diagnosed hypogonadism requiring hormonal therapy
Current testosterone replacement therapy or other medications affecting androgen status
Severe cardiovascular, hepatic or renal diseases in the stage of decompensation
Acute infectious or inflammatory diseases at the time of examination
Trial population
The study population will consist of middle-aged men aged 35-59 years residing in the Andijan region of Uzbekistan. Participants will be recruited through voluntary participation using community-based announcements, primary healthcare institutions, social media platforms and workplace outreach. Eligible participants will undergo standardized anthropometric assessment, functional performance testing, validated questionnaires evaluating lifestyle-related and psychoemotional factors, and laboratory determination of serum total testosterone levels.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Observational Assessment
Other interventionParticipants undergo standardized anthropometric measurements, functional performance tests, validated questionnaires assessing lifestyle-related and psychoemotional factors, and laboratory determination of serum total testosterone levels. No therapeutic or preventive intervention is administered.
Treatment groups
Trial outcomes
Primary outcomes
Serum Total Testosterone Level
Serum total testosterone concentration measured in fasting venous blood samples collected between 7:00 and 10:00 AM using standardized immunochemiluminescent assay methods.
Secondary outcomes
Association between body mass index and decreased testosterone levels
Assessment of the association between body mass index and decreased serum total testosterone levels.
Association between waist circumference and decreased testosterone levels
Evaluation of abdominal obesity assessed by waist circumference as a factor associated with decreased serum total testosterone levels.
Association between hand-grip strength and decreased testosterone levels
Assessment of hand-grip strength as a functional indicator associated with serum total testosterone levels.
Association between physical activity level and decreased testosterone levels
Assessment of physical activity level using the International Physical Activity Questionnaire (IPAQ) and its association with decreased serum total testosterone levels.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Andijan State Medical Institute
Lead sponsor
Tashkent Medical Academy
Collaborator
This trial is not recruiting at the moment. You can still explore other options: